Potassium channel openers exhibit cross-tolerance with morphine in two experimental models of pain
- PMID: 21473392
Potassium channel openers exhibit cross-tolerance with morphine in two experimental models of pain
Abstract
Objective: The study was performed to assess the effect of potassium channel openers on morphine tolerance and vice-versa.
Methods: Swiss albino mice of either gender weighing between 25-30 g were used for the study The study assesses the effect of potassium channel openers (cromakalim, diazoxide and minoxidil) on morphine tolerance and vice-versa, using formalin and tail-flick tests.
Results: The antinociceptive effect of cromakalim and minoxidil was significantly reduced when administered to morphine-tolerant mice, in both the behavioural tests. However reduced analgesic effect of diazoxide was observed on morphine-tolerance in the formalin test but not in the tail-flick test. Tolerance was observed when morphine was administered to animals chronically treated with any of the potassium channel openers. The same effect was observed when morphine was injected into a group treated with a combination of morphine and any of the potassium channel openers.
Conclusions: This study, therefore, suggests that both morphine and potassium channel openers are cross-tolerant. However such interaction occurs at the level of potassium channels rather than at the level of receptors.
Similar articles
-
Interaction of morphine and potassium channel openers on experimental models of pain in mice.Fundam Clin Pharmacol. 2011 Aug;25(4):479-84. doi: 10.1111/j.1472-8206.2010.00880.x. Epub 2010 Sep 30. Fundam Clin Pharmacol. 2011. PMID: 20880384
-
Antinociceptive activity of intrathecally administered potassium channel openers and opioid agonists: a common mechanism of action?J Pharmacol Exp Ther. 1993 Oct;267(1):390-9. J Pharmacol Exp Ther. 1993. PMID: 8229767
-
The involvement of K(ATP) channels in morphine-induced antinociception and hepatic oxidative stress in acute and inflammatory pain in rats.Fundam Clin Pharmacol. 2013 Dec;27(6):623-31. doi: 10.1111/fcp.12004. Epub 2012 Oct 3. Fundam Clin Pharmacol. 2013. PMID: 23033987
-
New windows on the mechanism of action of K(ATP) channel openers.Trends Pharmacol Sci. 2000 Nov;21(11):439-45. doi: 10.1016/s0165-6147(00)01563-7. Trends Pharmacol Sci. 2000. PMID: 11121575 Review.
-
K+ channel openers and insulin release.Life Sci. 1992;51(11):795-806. doi: 10.1016/0024-3205(92)90606-p. Life Sci. 1992. PMID: 1522743 Review.
Cited by
-
Morphine Efficacy, Tolerance, and Hypersensitivity Are Altered After Modulation of SUR1 Subtype KATP Channel Activity in Mice.Front Neurosci. 2019 Oct 22;13:1122. doi: 10.3389/fnins.2019.01122. eCollection 2019. Front Neurosci. 2019. PMID: 31695594 Free PMC article.
-
Analgesic effect of piracetam on peripheral neuropathic pain induced by chronic constriction injury of sciatic nerve in rats.Neurochem Res. 2014 Aug;39(8):1433-9. doi: 10.1007/s11064-014-1329-8. Epub 2014 May 16. Neurochem Res. 2014. PMID: 24831122